| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $25.7M-46.8% | $48.2M+63.7% | $29.5M-37.7% | $47.3M+5.3% | $44.9M+82.1% | $24.7M-44.4% | $44.4M |
| General and administrative | $9.6M-19.3% | $11.9M-10.8% | $13.3M-13.3% | $15.4M+36.3% | $11.3M+13.0% | $10.0M-17.8% | $12.2M |
| Loss from operations | -$35.3M+41.3% | -$60.1M-40.5% | -$42.8M+31.7% | -$62.7M-11.5% | -$56.2M-54.4% | -$36.4M+42.3% | -$63.1M |
| Interest income | $3.3M-46.3% | $6.2M-15.4% | $7.3M+211.7% | $2.3M+1167.5% | $185K-36.6% | $292K-81.0% | $1.5M |
| Interest expense | -$1.9M+1.1% | -$1.9M+7.0% | -$2.1M-22.3% | -$1.7M+2.8% | -$1.7M+8.5% | -$1.9M-215.3% | -$604K |
| Total other income, net | $1.4M-66.7% | $4.3M-18.8% | $5.3M+701.3% | $655K+142.1% | -$1.6M+3.4% | -$1.6M-271.9% | $938K |
| Net loss | -$33.8M+39.4% | -$55.9M-48.8% | -$37.5M+39.5% | -$62.0M-7.4% | -$57.8M-53.8% | -$37.6M+38.3% | -$60.8M |
| Net loss per share - basic | -$0.56+40.4% | -$0.94-46.9% | -$0.64+39.6% | -$1.06+0.9% | -$1.07 | — | — |
| Net loss per share - diluted | -$0.56+40.4% | -$0.94-46.9% | -$0.64+39.6% | -$1.06+0.9% | -$1.07 | — | — |
| Weighted average common shares outstanding - basic | 60.1M+1.0% | 59.5M+0.9% | 58.9M+0.9% | 58.4M+8.1% | 54.0M | — | — |
| Weighted average common shares outstanding - diluted | 60.1M+1.0% | 59.5M+0.9% | 58.9M+0.9% | 58.4M+8.1% | 54.0M | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.